Status:
RECRUITING
Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA
Lead Sponsor:
Danish Dementia Research Centre
Collaborating Sponsors:
Danish Reference Center for Prion Diseases, Rigshospitalet
Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Rigshospitalet
Conditions:
Idiopathic Anosmia
Idiopathic Hyposmia
Eligibility:
All Genders
55-75 years
Brief Summary
Test of early warning signs and RT-QuIC in patients with idiopathic olfactory dysfunction
Detailed Description
Background. The number of persons living with dementia is increasing in Denmark and worldwide because the population is generally growing older. Dementia with Lewy bodies (DLB) is the second most prev...
Eligibility Criteria
Inclusion criteria with patients iOD:
- Age 55 -75 years of age
- Slowly progressing and non-fluctuating iOD
- Able to give informed consent and to cooperate as evaluated by the PI
Exclusion criteria with patients iOD:
- Diagnosed with a neurodegenerative disease or major neurological/psychiatric condition.
- Anosmia/hyposmia caused by sino-nasal disease (including chronic rhinitis and allergy), after trauma, infection, congenial, olfactory dysfunction due to surgery, or toxins/drugs affecting the olfactory function.
- Olfactory dysfunction with response to systemic or local corticosteroids if tried
- Severe nasal cavity abnormalities or infections.
- Overt signs of dementia or PD
- Current alcohol or drug abuse
- Terminal illness
- Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
Inclusion criteria controls:
- Age 55 -75 years of age
- Able to give informed consent
- Able to cooperate as evaluated by the PI
Exclusion criteria controls:
- Olfactory dysfunction on clinical test
- Overt signs of dementia or PD
- Severe nasal cavity abnormalities or infections.
- Current alcohol or drug abuse
- Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
Key Trial Info
Start Date :
February 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2032
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05740683
Start Date
February 1 2023
End Date
December 1 2032
Last Update
October 2 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Dementia Research Centre
Copenhagen, Denmark, 2100
2
Oskar McWilliam
Copenhagen, Denmark, 2100